Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis

Isbister, Geoffrey K., Brown, Simon G., Macdonald, Ellen, White, Julian and Currie, Bart J. (2008). Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Medical Journal of Australia,188(8):473-476.

Document type: Journal Article
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading Currie_7357.pdf Published version application/pdf 122.55KB 81
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

IRMA ID s994677xPUB137
Title Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis
Author Isbister, Geoffrey K.
Brown, Simon G.
Macdonald, Ellen
White, Julian
Currie, Bart J.
Journal Name Medical Journal of Australia
Publication Date 2008
Volume Number 188
Issue Number 8
ISSN 0025-729X   (check CDU catalogue  open catalogue search in new window)
Start Page 473
End Page 476
Total Pages 4
Place of Publication Australia
Publisher Australiasian Medical Publishing Company
Field of Research 1103 - Clinical Sciences
HERDC Category C1 - Journal Article (DEST)
Abstract Objective: To investigate current use of Australian snake antivenoms and the frequency and severity of immediate-type hypersensitivity reactions.

Design:
Nested prospective cohort study as part of the Australian Snakebite Project.
Patients and setting:Patients receiving snake antivenom in Australian hospitals between 1 January 2002 and 30 November 2007.

Main outcome measures:
The use of CSL Limited antivenom; frequency and severity of hypersensitivity reactions to antivenom; premedication and treatment of these reactions.

Results
: Snake antivenom was administered to 195 patients, mostly for venom-induced consumption coagulopathy (145 patients, 74%), followed by non-specific systemic effects (12%), neurotoxicity (5%) and myotoxicity (4%). Antivenom was given to nine patients (5%) without evidence of envenoming or who were bitten by a species of snake for which antivenom is not required. The commonest antivenoms used were brown snake (46%), tiger snake (30%) and polyvalent (11%). The median dose was four vials (interquartile range, 2–5 vials), and 24 patients received two different types of antivenom. Immediate-type hypersensitivity reactions occurred in 48 patients (25%); 21 satisfied our definition of anaphylaxis, with 11 moderate and 10 severe cases, including nine in which patients were hypotensive. The remaining 27 reactions were mild (skin only). Adrenaline was used in 26 cases with good effect. The frequency of reactions to tiger snake (41%) and polyvalent (41%) antivenoms was higher than that to brown snake antivenom (10%). Hypersensitivity reactions occurred in 11 of 40 patients receiving any form of premedication (28%) and in 2 of 11 given adrenaline for premedication (18%) versus 20 of 86 not receiving premedication (23%).

Conclusions
: Antivenom was used appropriately, and most commonly for coagulopathy. Hypersensitivity reactions were common, but most were not severe. The discretionary use of premedication was not associated with any reduction in reactions.
Description for Link Link to published version
URL https://www.mja.com.au/journal/2008/188/8/current-use-australian-snake-antivenoms-and-frequency-immediate-type


© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact digitisation@cdu.edu.au.

 
Versions
Version Filter Type
Access Statistics: 63 Abstract Views, 82 File Downloads  -  Detailed Statistics
Created: Tue, 28 Apr 2009, 14:49:10 CST by Sarena Wegener